Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Takashi Hisai
Phase 2 Study of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma
Journal of Gastroenterology
Gastroenterology
Related publications
Gemcitabine Plus Carboplatin in Patients With Advanced Hepatocellular Carcinoma: Results of a Phase II Study
ISRN Oncology
Impact of Adverse Events on the Progression-Free Survival of Patients With Advanced Hepatocellular Carcinoma Treated With Lenvatinib: A Multicenter Retrospective Study
Drugs - Real World Outcomes
Pharmacology
Carnitine Insufficiency Is Associated With Fatigue During Lenvatinib Treatment in Patients With Hepatocellular Carcinoma
PLoS ONE
Multidisciplinary
A Clinical Phase II Study of Sorafenib in Advanced Hepatocellular Carcinoma
Anaplastology
The Three Criteria for Radiological Response on Survival in Patients With Hepatocellular Carcinoma Treated With Lenvatinib
Hepatology Research
Hepatology
Infectious Diseases
A Phase II Study of Cixutumumab (IMC-A12, NSC742460) in Advanced Hepatocellular Carcinoma
Journal of Hepatology
Hepatology
Thymostimulin in Advanced Hepatocellular Carcinoma: A Phase II Trial
BMC Cancer
Cancer Research
Oncology
Genetics
High Immunosuppressive Burden in Advanced Hepatocellular Carcinoma Patients
OncoImmunology
Oncology
Allergy
Immunology
Lenvatinib and Its Use in the Treatment of Unresectable Hepatocellular Carcinoma
Future Oncology
Medicine
Cancer Research
Oncology
